MediciGlobal Expands its Outreach with Patient-Based Organizations
A leader in patient recruitment for clinical trials, MediciGlobal adds an experienced executive to build and expand partnerships with patient and community-based groups.
King of Prussia, PA- (January 20, 2011) – MediciGlobal, the global leader in clinical trial recruitment and retention today announced the appointment of David Albaugh as Director of Patient Communications and Advocacy.
Social networking among patients and online advocacy groups around the world are spreading at an unprecedented rate. MediciGlobal has been at the forefront of this change. Today, many of Medici’s patient recruitment programs integrate eMarketing/internet advertising/social media and online advocacy. The knowledge and skill set required to master the dynamics of a continuously changing online marketing environment has required fundamental changes in staffing and recruitment management. Experienced digital advertisers are replacing traditional media buyers; advocacy managers must have in-depth social media expertise coupled with national and international advocacy relations.
In the continuation of its leadership role in patient-centric recruitment programs for clinical trials, MediciGlobal has added Albaugh to lead its evolving communications strategy, including Alliance Development and Advocacy.
Bringing clinical trials to patients requires in-depth knowledge of clinical trials and study protocols, coupled with expertise in translating science to a level patients can understand. Albaugh brings both science and communications to achieve this at MediciGlobal. Along with more than 14 years of experience in healthcare/pharmaceutical product and technology communications, medical/patient alliance development, public relations and communications, he also brings another 12 years experience in R&D, artfully bringing a unique combination of scientific and creative thinking.
MediciGlobal prides itself on delivering innovative patient-centered marketing solutions to its clients and to support these efforts Albaugh will be leading the company’s outreach to patient-based organizations in a number of disease states. “Over the past 20 years patients have become much more active participants in their healthcare decisions, “ stated Albaugh. “To ensure that Mediciglobal continues to be a leader in clinical trial recruitment we need to partner with the groups that represent the needs of the patient.”
“As our unique patient-centric approach continues to evolve we need to continually adapt to the changing healthcare landscape,” says Liz Moench, CEO of Mediciglobal. “David’s valuable combination of skills enables him to develop creative communications programs that address the patient, clinical, caregiver, and technical aspects of clinical trial recruitment.”
###
About MediciGlobal
MediciGlobal is in the business of making a meaningful difference to patient health—by identifying and engaging patients for clinical trials, and by building deep and lasting connections with our many stakeholders. Our clinical trial recruitment practices are guided by global standards and by our concern for the lives of the patients who put their trust in us. We’re also making certain that those who participate in these trials fully understand what clinical trial participation means, and that their participation is guarded by strict privacy policies. MediciGlobal meets BBB OnLine® and WBENC accreditation standards and is certified as a Safe Harbor company. Visit www.mediciglobal.com and follow the company on Facebook at www.facebook.com/MediciGlobal.
www.mediciglobal.com
For further information contact:
Alicia Carango
+1 484-674-6855
acarango@MediciGlobal.com
